Barclays maintain an 'Equalweight' rating on Healthways (HWAY); Medicare Pilot Follow Up: Updating 2010 Estimates for One-Time Favorable Items
Tweet Send to a Friend
Barclays maintain an 'Equalweight' rating on Healthways (NASDAQ: HWAY), PT $12.
Barclays analyst says, "Monday evening after the close, Healthways ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Monday evening after the close, Healthways ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
